Drugs / IONIS-STAT3Rx
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01563302 | Feb 2012 → Mar 2016 | diffuse large B-cell lymphoma, high grade malignant neoplasm | Ionis Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IONIS-STAT3Rx | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01563302 ↗ |